Immersion Sees Q2 Revs $10.5M-$11M Vs $8.05M Est
Revenues to be between $10.5 to $11.0 million
GAAP Operating expenses to be between $5.1 and $5.5 million
GAAP Net Income to be between $5.0 and $5.5
Biofrontera Sees June 2021 Revs €2.626M Vs €1.75M YoY
Biofrontera AG (NASDAQ:BFRA, Frankfurt Stock Exchange: B8F)))) (the "Company"), an international biopharmaceutical company, today reported preliminary, unaudited revenue for the month of June 2021.
The
Middleby Sees Q2 2021 Revs $808M Vs $793.61M Est.; Sees FY21 Revs $3.244B Vs $3.16B Est
The Middleby Corporation (NASDAQ:MIDD) ("Middleby") today is releasing its current Q2 2021 and fiscal year 2021 forecast, well ahead of prior management forecasts and current consensus estimates. We
Cano Health Updates Guidance To Reflect DMC Acquisition; Raises FY21 Sales Guidance From $1.4B-$1.5B To $1.5B, Sees FY22 Sales $2.23B vs $2.15B Est.
Guidance Update
With the close of the DMC acquisition, Cano Health is updating its previous guidance given on June 14, 2021. In contrast to prior 2021 guidance, which included projections forGuidance Update
The Week In Cannabis: Justice Clarence Thomas, Mexico’s Decriminalization, Apple’s Policy Changes, Tilray And More
Below is a recap of the main news related to the cannabis industry and markets for the week of June 28, 2021.
Neenah Outlines Operational Changes Aimed At Accelerating Growth, Strengthening Margins, Creating Value For Customers, Shareholders
Neenah, Inc. (NYSE:NP), a leading global manufacturer of specialty materials focused on filtration media, specialty coatings, engineered materials and imaging & packaging, today announced a number of operational
The Daily Biotech Pulse: Iterum’s Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical Announce CFO Departures
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 1)
Outset Medical Sees Q2 2021 Net Revenue $24M-$25M
Outset announced that preliminary unaudited net revenue for the second quarter of 2021 is expected to be in the range of $24.5 million to $25.0 million, representing growth
PreMarket Prep Stock Of The Day: Micron Technology
Benzinga's PreMarket Prep airs every morning from 8-9 a.m. ET. During that fast-paced, highly informative hour, traders and investors tune in to get the major news of the day, the catalysts behind those moves and the corresponding price action for the upcoming session.
Horace Mann Raises 2021 EPS Guidance From $3.00-$3.20 To $3.50-$3.70
Horace Mann Educators Corporation (NYSE:HMN) today announced it is raising guidance for its 2021 EPS by more than 15% to $3.50 to $3.70 from $3.00 to $3.20, with